Last Updated: Tuesday, January 31, 2012, 12:59
Shares of Glenmark Pharmaceuticals tumbled by nearly 7 percent on Tuesday after the company's net profit declined by 46.70 percent in the quarter ended December 31, 2011.
Last Updated: Monday, January 30, 2012, 18:09
Glenmark Pharmaceuticals on Monday said its consolidated net profit declined by 46.70 percent to Rs 46.11 crore for the quarter ended December 31, 2011 over the same period last fiscal due to forex loss.
Last Updated: Sunday, January 15, 2012, 12:23
Glenmark Pharmaceuticals expects sales of its speciality business, which focuses on branded products, to grow by around 20 percent in India in the next three years.
Last Updated: Tuesday, December 13, 2011, 13:50
Glenmark Pharmaceuticals said on Tuesday it has sought an arbitration in the US as Napo Pharmaceuticals has no basis for terminating a collaboration agreement with it to develop and market an HIV-associated diarrhoea drug.
Last Updated: Monday, November 7, 2011, 19:53
Drug firm Glenmark Pharmaceuticals Monday said it has received a payment of USD 5 million (over Rs 24 crore) from Sanofi-Aventis on completion of Phase I study of molecule.
Last Updated: Tuesday, July 26, 2011, 11:02
Glenmark Pharmaceuticals said on Tuesday it has received USD 15 million from US-based Salix Pharmaceuticals towards upgrading the manufacturing facility for HIV-associated diarrhea drug 'Crofelemer'.
Last Updated: Monday, July 18, 2011, 13:56
Glenmark Pharmaceuticals Monday said it has received final approval from the US health regulator to market generic Nizatidine capsules, used for treating ulcers, in the American market.
more videos >>
